Next Article in Journal
Synergistic Anti-Tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer
Previous Article in Journal
Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?
 
 
Article

Article Versions Notes

Livers 2022, 2(4), 336-343; https://doi.org/10.3390/livers2040025
Action Date Notes Link
article xml file uploaded 21 October 2022 11:02 CEST Original file -
article xml uploaded. 21 October 2022 11:02 CEST Update -
article pdf uploaded. 21 October 2022 11:02 CEST Version of Record https://www.mdpi.com/2673-4389/2/4/25/pdf
article html file updated 21 October 2022 11:04 CEST Original file -
article xml file uploaded 21 October 2022 11:20 CEST Update -
article xml uploaded. 21 October 2022 11:20 CEST Update https://www.mdpi.com/2673-4389/2/4/25/xml
article html file updated 21 October 2022 11:21 CEST Update -
article html file updated 1 March 2023 23:28 CET Update https://www.mdpi.com/2673-4389/2/4/25/html
Back to TopTop